secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2025-12-09T23:59:59+00:00
Accession:  0001104659-25-119494
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics appoints Dr. Murphy and Dr. Lee to Board, expanding from six to eight members
--------------------------------------------------------------------------------

- Board expanded from six to eight directors; Dr. Murphy (Class III, term to 2027) and Dr. Lee (Class II, term to 2026) appointed.
- Dr. Murphy brings life science investment experience; Dr. Lee brings corporate development and CFO background from biotech firms.
- Each new director received an initial option grant of 88,000 shares vesting over 36 months and a $40,000 annual cash retainer.
- Dr. Murphy joins Compensation and Nominating/Governance Committees; Dr. Lee joins Audit and Compensation Committees.
- Appointments effective December 9, 2025; both deemed independent under Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465925119494/0001104659-25-119494-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465925119494/tm2532966d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-119494

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer